Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02360917 : Emerging From the Hazeā„¢- Measuring the Impact of a Psycho-education Program on Perceived Cognition After Breast Cancer Treatment
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

- Completed treatment for stage 1-3 breast cancer at least two months but not more than
24 months prior to enrollment.

- Having received chemotherapy with or without radiation therapy

- Female, Age ?18 years.

- FACT-Cog score less than 59 on the Perceived Cognitive Impairment subscale

- Eligible after 2 months of completing all their active cancer treatment with the
exception of long-term hormonal treatments or trastuzumab.

- Subjective complaint of cognitive concerns at time of enrollment

- Must be able to understand and communicate proficiently in English

- Ability to understand and the willingness to sign a written informed consent.

- Agree to complete study surveys

Exclusion Criteria:

- Patients who have significant personality disorders or unstable psychiatric disorders
(including active major depression, substance abuse, psychosis or bipolar disorder)
as assessed by the interviewing clinician

- Patients with known brain metastases, history of brain metastases or radiation to the

- Patients with a history of stroke or other pre-existing neurological condition that
may contribute to cognitive dysfunction.

- Non-English speakers

- Receiving treatment for another malignancy other than breast cancer

- Uncontrolled intercurrent illness including, but not limited to, ongoing or active
infection, chronic anemia, uncontrolled hypothyroidism, symptomatic congestive heart
failure, unstable angina pectoris, uncontrolled cardiac arrhythmia, or psychiatric
illness/social situations that would limit compliance with study requirements.
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557